Russians claim to have an effective treatment for the coronavirus, which hospitals will start using in June
Finished tablets cascade down the channels of a packaging machine during the manufacture of the Favipiravir antiviral medicine, a joint venture between the Russian Direct Investment Fund (RDIF) and ChemRar group, at a plant in Khimki, Russia, on Monday, May 18, 2020.
Russia has approved an anti-influenza drug to treat Covid-19 and will start delivering courses of the drug, Avifavir, to hospitals in June, according to Russia’s sovereign wealth fund (RDIF).
RDIF has provided funding into Russia’s development and production of the drug which is based on favipiravir, an anti-influenza drug first developed in Japan under the name Avigan, in a 50-50 joint venture with Russian pharmaceutical firm ChemRar.
Preliminary trials appeared to show that it could shorten recovery times for patients with Covid-19. The final stage of Avifavir clinical trials involving 330 patients, are ongoing, RDIF and ChemRar said Monday, but …continued .
[Source: CNBC News]